Neutrophil Priming in Host Defense: Role of Oxidants as Priming Agents
- 1 February 2002
- journal article
- review article
- Published by Mary Ann Liebert Inc in Antioxidants and Redox Signaling
- Vol. 4 (1) , 69-83
- https://doi.org/10.1089/152308602753625870
Abstract
Neutrophils play an essential role in the body's innate immune response to infection. To protect the host, these phagocytic cells possess an impressive array of microbicidal weapons that can be brought to bear on an invading pathogen, including a variety of toxic oxygen radical species and proteolytic enzymes. Although the neutrophil response is designed to restrict the damage to the smallest possible region where the pathogen is located, some of the damaging agents inevitably leak into the surrounding areas where they have the capacity to inflict tissue damage at sites of inflammation. Thus, it is essential that the host defense response of these cells is finely tuned to result in the appropriate level of response to any given situation. One of the regulatory mechanisms implicated in controlling neutrophil responses is priming. Through the action of priming agents, the level of activation and subsequent responses of the cell can be regulated so that a continuum of activation states is achieved. In this review, we describe key features of the priming response in host defense and disease pathogenesis and focus on the unique role of reactive oxygen species as priming agents.Keywords
This publication has 81 references indexed in Scilit:
- Effects of recombinant tumor necrosis factor (rHuTNFα)on human neutrophils and monocytes: In vitro, ex vivo and in vivoEuropean Journal of Haematology, 2009
- Recent advances torwards understanding redox mechanisms in the activation of nuclear factor κbFree Radical Biology & Medicine, 2000
- Activation of NF‐κB in human neutrophils during phagocytosis of bacteria independently of oxidant generationFEBS Letters, 1998
- Signal transduction through NF-κBImmunology Today, 1998
- Bactericidal/Permeability-Increasing Protein Release in Whole Blood Ex Vivo: Strong Induction by Lipopolysaccharide and Tumor Necrosis Factor-The Journal of Infectious Diseases, 1997
- The N-formyl methionyl peptide, formyl-methionyl-leucyl phenylalanine (fMLF) increases the lateral diffusion of complement receptor 1 (CR1/CD35) in human neutrophils; a causative role for oxidative metabolites?Bioscience Reports, 1996
- Evidence for nitric oxide‐mediated oxidative damage in chronic inflammation Nitrotyrosine in serum and synovial fluid from rheumatoid patientsFEBS Letters, 1994
- Receptor expression and oxidase activity in human neutrophils: Regulation by granulocyte-macrophage colony-stimulating factor and dependence upon protein biosynthesisBioscience Reports, 1990
- Regulation of chemoattractant receptor interaction with transducing proteins by organizational control in the plasma membrane of human neutrophils.The Journal of cell biology, 1989
- Effect of tumor necrosis factor on granule release and LTB4 production in adherent human polymorphonuclear leukocytesInflammation Research, 1989